Medpace Holdings, Inc. (MEDP) vs Verisk Analytics, Inc. (VRSK)
A side-by-side comparison of Medpace Holdings, Inc. and Verisk Analytics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: MEDP is classified in Healthcare; VRSK is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
MEDP
Medpace Holdings, Inc.
$570.97HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
VRSK
Verisk Analytics, Inc.
$212.26TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — MEDP vs VRSK
growth of $100 · dividends reinvested · last 10yMEDP +2020.8%VRSK +166.7%MEDP compounded faster
Log scale — wide-divergence pair
MEDP VRSK
MEDP vs VRSK: by the numbers
- •VRSK is the larger company ($27.81B vs $15.94B market cap).
- •VRSK trades at the lower trailing earnings multiple (31.46 vs 34.53 P/E), one valuation lens rather than an overall verdict.
- •VRSK converts more revenue to profit (29.34% vs 17.67% net margin).
- •MEDP grew revenue faster over the past five years (22.03% vs 1.92% CAGR).
- •VRSK pays a dividend (0.92% yield), while MEDP has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MEDP | VRSK |
|---|---|---|
| P/E ratio | 34.53 | 31.46 |
| Forward P/E | 33.60 | 26.96 |
| P/S ratio | 6.09 | 9.01 |
| P/B ratio | 39.07 | 92.99 |
| PEG ratio | 1.82 | 3.81 |
| EV / EBITDA | 27.73 | 18.83 |
| FCF yield | 4.51% | 4.03% |
Profitability
| Metric | MEDP | VRSK |
|---|---|---|
| Gross margin | 28.76% | 67.44% |
| Operating margin | 20.97% | 44.87% |
| Net margin | 17.67% | 29.34% |
| ROE | 113.29% | 293.95% |
| ROIC | 67.94% | 19.56% |
Dividends
| Metric | MEDP | VRSK |
|---|---|---|
| Dividend yield | N/A | 0.92% |
| Payout ratio | N/A | 29.19% |
Growth (annualized)
| Metric | MEDP | VRSK |
|---|---|---|
| Revenue CAGR (5Y) | 22.03% | 1.92% |
| EPS CAGR (5Y) | 30.90% | 8.25% |
| FCF CAGR (5Y) | 24.42% | 4.58% |
| Total return CAGR (5Y) | 28.06% | 2.75% |
Frequently asked
- Which has the lower trailing P/E, MEDP or VRSK?
- VRSK has the lower trailing P/E: MEDP trades at 34.53 and VRSK at 31.46. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, MEDP or VRSK?
- Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus VRSK at 1.92%.
- Does MEDP or VRSK pay a bigger dividend?
- VRSK pays a dividend (0.92% yield), while MEDP has no payments in the available dividend history.
- Is MEDP or VRSK more profitable?
- VRSK runs the higher net margin — MEDP at 17.67% versus VRSK at 29.34%.
- How have MEDP and VRSK total returns compared?
- Over the past 5 years, MEDP delivered 28.06% and VRSK delivered 9.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Medpace P/E ratioVerisk Analytics P/E ratioMedpace dividend yieldVerisk Analytics dividend yieldMedpace ROEVerisk Analytics ROEMedpace operating marginVerisk Analytics operating marginMedpace revenue growthVerisk Analytics revenue growthMedpace free cash flowVerisk Analytics free cash flow
Medpace & Verisk Analytics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.